Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

[Clinical value of changes in red blood cell ultrastructure and energy metabolism in children with cystic fibrosis].

Badriashvili NR, Chikovani MM, Topuridze MA, Glonti SZ, Sharikadze NV, Topuria TIu, Pagava KI.

Georgian Med News. 2011 Apr;(193):30-4. Russian.

PMID:
21617271
2.

[Clinical value of changes in red blood cell ultrastructure and energy metabolism in children with cystic fibrosis of the pancreas].

Badriashvili NR, Topuridze NL, Chakhunashvili GS, Tabutsadze DO, Khvitisiashvili NO.

Georgian Med News. 2006 Jun;(135):73-8. Russian.

PMID:
16905815
3.

[Clinical significance of the changes in the ultrastructure and the energy system of erythrocytes in children with mucoviscidosis].

Badriashvili NR, Kvachadze IM, Korobko IuA, Kapranov NI, Niiazova MKh.

Pediatriia. 1987;(10):43-8. Russian. No abstract available.

PMID:
3696858
4.

Changes in erythrocyte membrane ATPase in patients with cystic fibrosis of the pancreas.

Cole CH, Dirks JH.

Pediatr Res. 1972 Jul;6(7):616-21. No abstract available.

PMID:
4262554
5.

Measuring the impedance of erythrocytes in patients with cystic fibrosis.

Zöllner H, König A, Jährig K.

Acta Univ Carol Med (Praha). 1990;36(1-4):58-61.

PMID:
2130719
6.

In vitro study of the incorporation and transport of nonesterified fatty acids into the phospholipids of the red blood cell membranes of cystic fibrosis patients.

Rogiers V, Mandelbaum I, Mozes N, Vertongen F, Dab I, Crokaert R, Vis HL.

Pediatr Res. 1982 Sep;16(9):761-8.

PMID:
7133810
7.

Altered peroxide metabolism in erythrocytes from children with cystic fibrosis.

Matkovics B, Gyurkovits K, László A, Szabó L.

Clin Chim Acta. 1982 Oct 13;125(1):59-62.

PMID:
7139949
8.

Serotonin metabolism in cystic fibrosis.

Partington MW, Ferguson AC.

Arch Dis Child. 1977 May;52(5):386-90.

9.

Mineral metabolism in erythrocytes from patients with cystic fibrosis.

Vormann J, Günther T, Magdorf K, Wahn U.

Eur J Clin Chem Clin Biochem. 1992 Apr;30(4):193-6.

PMID:
1525247
10.
11.

Antioxidant status in erythrocytes of cystic fibrosis children.

Laskowska-Klita T, Chełchowska M.

Acta Biochim Pol. 2001;48(1):283-5.

12.

Energy content of stools in normal healthy controls and patients with cystic fibrosis.

Murphy JL, Wootton SA, Bond SA, Jackson AA.

Arch Dis Child. 1991 Apr;66(4):495-500.

13.

Abnormal electrophoretic mobility of erythrocytes in cystic fibrosis: evidence for a membrane defect.

Hein J, Seyfarth M, Jenssen HL, Köhler HJ.

Padiatr Grenzgeb. 1985;24(4):331-40. No abstract available.

PMID:
4034213
14.

Abnormal fatty acid turnover in the phospholipids of the red blood cell membranes of cystic fibrosis patients (in vitro study).

Rogiers V, Dab I, Michotte Y, Vercruysse A, Crokaert R, Vis HL.

Pediatr Res. 1984 Aug;18(8):704-9.

PMID:
6472942
15.

Increased energy expenditure in cystic fibrosis is associated with specific mutations.

O'Rawe A, McIntosh I, Dodge JA, Brock DJ, Redmond AO, Ward R, Macpherson AJ.

Clin Sci (Lond). 1992 Jan;82(1):71-6.

PMID:
1310920
16.

Increased Na+/Mg2+ antiport in erythrocytes of patients with cystic fibrosis.

Vormann J, Magdorf K, Günther T, Wahn U.

Eur J Clin Chem Clin Biochem. 1994 Nov;32(11):833-6.

PMID:
7888479
17.

Anion transport and 2,3-diphosphoglycerate in cystic fibrosis red blood cells.

Berghout AG, Bender SW.

Pediatr Res. 1984 Oct;18(10):1017-20.

PMID:
6493845
18.

Erythrocytes of humans with cystic fibrosis fail to stimulate nitric oxide synthesis in isolated rabbit lungs.

Liang G, Stephenson AH, Lonigro AJ, Sprague RS.

Am J Physiol Heart Circ Physiol. 2005 Apr;288(4):H1580-5. Epub 2004 Dec 9.

20.

Decrease in insulin and insulin-like growth factor I (IGF-I) binding to erythrocytes from patients with cystic fibrosis.

Dooghe C, Grizard G, Labbe A, Grigorescu F, Dardevet D, Grizard J.

Diabetes Metab. 1997 Dec;23(6):511-8.

PMID:
9496557

Supplemental Content

Support Center